Monoclonal Antibodies To Basic Fibroblast Growth Factor

Patent No. EP2288717 (titled "Monoclonal Antibodies To Basic Fibroblast Growth Factor") was filed by Galaxy Biotech on May 28, 2009. The application was issued on Jul 5, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANApr 5, 2018VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2288717

GALAXY BIOTECH
Application Number
EP09759089A
Filing Date
May 28, 2009
Status
Revoked
Feb 26, 2021
Publication Date
Jul 5, 2017